Inhibition of C1-inh in rats with GBM, using appropriate antibodies, was found to increase survival but also led to decreased levels of cytokines IL-1β and GM-CSF, which are associated with an immunosuppressive tumor microenvironment (69, 99). The gene discussed is CSF2; the disease is glioblastoma.